安徽四通生物医药

Anhui Sitong Biological Medicine is a Chinese biotechnology company focused on the research and development of innovative pharmaceutical products. Established in 2018 and headquartered in the Hefei High-tech Industrial Development Zone, the company primarily targets the oncology therapeutic area. Sitong Biological Medicine leverages small molecule drug discovery platforms to develop candidates for various cancer indications. The company is part of the growing life sciences ecosystem in Anhui Province, emphasizing scientific innovation and the development of proprietary intellectual property. Its current operations are centered on early-stage research and pre-clinical development.